← Leaderboards
Robert S Negrin
Stanford University
$29,816,136
Attributed
$29,816,136
Total exposure
25
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$94,890,755 · 26
By mechanism
P01$83,485,896 · 16
R01$5,995,447 · 4
T32$2,121,364 · 1
RC2$1,934,524 · 1
U01$960,003 · 1
P30$393,521 · 3
Top collaborators
- David B. Miklos1 shared
Most similar at Stanford University
Same institution · by research overlap
- Samuel Strober$36,157,957
- Mark M Davis$39,722,191
- Edgar G. Engleman$35,389,843
- Judith Anne Shizuru$11,975,284
- Sandra J. Horning$4,271,994
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsClinicImmuneClinical TrialsBone Marrow TransplantationMalignant NeoplasmsT-LymphocyteBiologicalGraft-Vs-Host DiseaseBiologyBaseReactionAnimal ModelHematopoieticTranslatingInsightProgramsAllogenicHematologic NeoplasmsHematopoietic Cell TransplantationCytokineTumorAnimalsLaboratories
Grant awards (135)
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,936,016
P01 · FY2025 · CA · contact PI
Biology and Immunotherapy of iNKT Cells$469,026
P01 · FY2025 · CA · contact PI
Administration and Clinical Trial Coordination$175,477
P01 · FY2025 · CA · contact PI
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,735,488
P01 · FY2023 · CA · contact PI
Project 1: Immune Regulation in HCT$344,535
P01 · FY2023 · CA · contact PI
Core A: Administration and Clinical Trial Coordination Core$252,825
P01 · FY2023 · CA · contact PI
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,680,780
P01 · FY2022 · CA · contact PI
Project 1: Immune Regulation in HCT$337,646
P01 · FY2022 · CA · contact PI
Core A: Administration and Clinical Trial Coordination Core$247,767
P01 · FY2022 · CA · contact PI
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,735,488
P01 · FY2021 · CA · contact PI
Project 1: Immune Regulation in HCT$344,535
P01 · FY2021 · CA · contact PI
Core A: Administration and Clinical Trial Coordination Core$252,825
P01 · FY2021 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$17,842
T32 · FY2021 · HL · contact PI
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,739,423
P01 · FY2020 · CA · contact PI
Project 1: Immune Regulation in HCT$344,521
P01 · FY2020 · CA · contact PI
Role of Immune Regulatory Cells in GVHD Prevention and Tolerance Induction$317,497
P01 · FY2020 · HL · contact PI
Core A: Administration and Clinical Trial Coordination Core$252,815
P01 · FY2020 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$98,360
T32 · FY2020 · HL · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$43,892
P30 · FY2020 · CA · contact PI
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma$2,745,884
P01 · FY2019 · CA · contact PI
Project 1: Immune Regulation in HCT$344,497
P01 · FY2019 · CA · contact PI
Role of Immune Regulatory Cells in GVHD Prevention and Tolerance Induction$317,497
P01 · FY2019 · HL · contact PI
Core A: Administration and Clinical Trial Coordination Core$252,797
P01 · FY2019 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$149,321
T32 · FY2019 · HL · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$43,761
P30 · FY2019 · CA · contact PI
Imaging and Regulation of Immune Function in HCT$369,473
R01 · FY2018 · CA · contact PI
Role of Immune Regulatory Cells in GVHD Prevention and Tolerance Induction$313,535
P01 · FY2018 · HL · contact PI
Training Program in Hematopoietic Cell Transplantation$143,765
T32 · FY2018 · HL · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$43,896
P30 · FY2018 · CA · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$11,296
P30 · FY2018 · CA · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$7,796
P30 · FY2018 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$2,700,000
P01 · FY2017 · CA · contact PI
Immune Regulation in HCT$1,151,709
P01 · FY2017 · CA · contact PI
Role of Immune Regulatory Cells in GVHD Prevention and Tolerance Induction$312,059
P01 · FY2017 · HL · contact PI
Administration and Clinical Trial Coordination$258,741
P01 · FY2017 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$139,272
T32 · FY2017 · HL · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$32,997
P30 · FY2017 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$2,700,000
P01 · FY2016 · CA · contact PI
Immune Regulation in HCT$1,151,707
P01 · FY2016 · CA · contact PI
Regulatory T cells in allogeneic transplantation$522,036
R01 · FY2016 · HL · contact PI
Role of Immune Regulatory Cells in GVHD Prevention and Tolerance Induction$352,785
P01 · FY2016 · HL · contact PI
Administration and Clinical Trial Coordination$258,742
P01 · FY2016 · CA · contact PI
Immunology & Immunotherapy of Cancer Research Program (Project-006)$36,782
P30 · FY2016 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$2,700,000
P01 · FY2015 · CA · contact PI
Immune Regulation in HCT$1,151,707
P01 · FY2015 · CA · contact PI
Regulatory T cells in allogeneic transplantation$514,205
R01 · FY2015 · HL · contact PI
Administration and Clinical Trial Coordination$258,742
P01 · FY2015 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$89,111
T32 · FY2015 · HL · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$2,619,001
P01 · FY2014 · CA · contact PI
Immune Regulation in HCT$1,117,156
P01 · FY2014 · CA · contact PI
Regulatory T cells in allogeneic transplantation$511,595
R01 · FY2014 · HL · contact PI
Role of Regulatory T cells in GVHD, GVT, and Tolerance Induction$274,277
P01 · FY2014 · HL · contact PI
Administration and Clinical Trial Coordination$250,980
P01 · FY2014 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$130,347
T32 · FY2014 · HL · contact PI
Hematopoetic$52,923
P30 · FY2014 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$2,700,000
P01 · FY2013 · CA · contact PI
Immune Regulation in HCT$1,151,706
P01 · FY2013 · CA · contact PI
Regulatory T cells in allogeneic transplantation$496,978
R01 · FY2013 · HL · contact PI
Role of Regulatory T cells in GVHD, GVT, and Tolerance Induction$266,441
P01 · FY2013 · HL · contact PI
Administration and Clinical Trial Coordination$258,743
P01 · FY2013 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$127,729
T32 · FY2013 · HL · contact PI
Hematopoetic$14,100
P30 · FY2013 · CA · contact PI
Regulatory T cells in allogeneic transplantation$520,186
R01 · FY2012 · HL · contact PI
NK Cells in GVHD and GVT$285,520
R01 · FY2012 · CA · contact PI
Role of Regulatory T cells in GVHD, GVT, and Tolerance Induction$279,874
P01 · FY2012 · HL · contact PI
Training Program in Hematopoietic Cell Transplantation$127,729
T32 · FY2012 · HL · contact PI
Hematopoetic$15,065
P30 · FY2012 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,462,150
P01 · FY2011 · CA · contact PI
NK Cells in GVHD and GVT$285,887
R01 · FY2011 · CA · contact PI
Role of Regulatory T cells in GVHD, GVT, and Tolerance Induction$279,874
P01 · FY2011 · HL · contact PI
Control of GVHD with Retained GVT$273,889
P01 · FY2011 · CA · contact PI
Allografting for Lukemia$266,530
P01 · FY2011 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$125,604
T32 · FY2011 · HL · contact PI
Hematopoetic$15,417
P30 · FY2011 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,583,412
P01 · FY2010 · CA · contact PI
Regulatory T Cells in Allogeneic Transplantation$750,258
RC2 · FY2010 · HL · contact PI
NK Cells in GVHD and GVT$295,059
R01 · FY2010 · CA · contact PI
Role of Regulatory T cells in GVHD, GVT, and Tolerance Induction$279,874
P01 · FY2010 · HL · contact PI
Control of GVHD with Retained GVT$258,832
P01 · FY2010 · CA · contact PI
Allografting for Lukemia$247,934
P01 · FY2010 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$75,594
T32 · FY2010 · HL · contact PI
Hematopoetic$17,352
P30 · FY2010 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,525,298
P01 · FY2009 · CA · contact PI
Regulatory T Cells in Allogeneic Transplantation$1,184,266
RC2 · FY2009 · HL · contact PI
NK Cells in GVHD and GVT$294,926
R01 · FY2009 · CA · contact PI
Control of GVHD with Retained GVT$254,789
P01 · FY2009 · CA · contact PI
Allografting for Lukemia$244,175
P01 · FY2009 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$22,494
T32 · FY2009 · HL · contact PI
PROG 8- Hematopoietic Cell Transplantation and$20,909
P30 · FY2009 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,446,067
P01 · FY2008 · CA · contact PI
REGULATORY T CELLS WHICH ALLOW GVT WITHOUT GVHD$374,902
P01 · FY2008 · HL · contact PI
NK Cells in GVHD and GVT$294,385
R01 · FY2008 · CA · contact PI
Control of GVHD with Retained GVT$247,944
P01 · FY2008 · CA · contact PI
Allografting for Lukemia$237,687
P01 · FY2008 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$121,483
T32 · FY2008 · HL · contact PI
PROG 8- Hematopoietic Cell Transplantation and$20,369
P30 · FY2008 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,353,514
P01 · FY2007 · CA · contact PI
REGULATORY T CELLS WHICH ALLOW GVT WITHOUT GVHD$395,353
P01 · FY2007 · HL · contact PI
Administration and Research Coordination$339,850
P01 · FY2007 · CA · contact PI
Visualizing Tumors and Mechanisms of Therapy in Vivo$234,613
R01 · FY2007 · CA · contact PI
Control of GVHD with Retained GVT$220,506
P01 · FY2007 · CA · contact PI
Allografting for Lukemia$213,006
P01 · FY2007 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$121,483
T32 · FY2007 · HL · contact PI
PROG 8- Hematopoietic Cell Transplantation and$16,966
P30 · FY2007 · CA · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,175,580
P01 · FY2006 · CA · contact PI
REGULATORY T CELLS WHICH ALLOW GVT WITHOUT GVHD$338,432
P01 · FY2006 · HL · contact PI
Visualizing Tumors and Mechanisms of Therapy in Vivo$234,603
R01 · FY2006 · CA · contact PI
Training Program in Hematopoietic Cell Transplantation$125,438
T32 · FY2006 · HL · contact PI
Bone Marrow Grafting for Leukemia and Lymphoma$3,165,316
P01 · FY2005 · CA
REGULATORY T CELLS WHICH ALLOW GVT WITHOUT GVHD$331,991
P01 · FY2005 · HL
Visualizing Tumors and Mechanisms of Therapy in Vivo$240,240
R01 · FY2005 · CA
Training Program in Hematopoietic Cell Transplantation$62,437
T32 · FY2005 · HL
Bone Marrow Grafting for Leukemia and Lymphoma$3,062,251
P01 · FY2004 · CA
REGULATORY T CELLS WHICH ALLOW GVT WITHOUT GVHD$321,097
P01 · FY2004 · HL
Visualizing Tumors and Mechanisms of Therapy in Vivo$240,231
R01 · FY2004 · CA
Training Program in Hematopoietic Cell Transplantation$117,067
T32 · FY2004 · HL
Bone Marrow Grafting for Leukemia and Lymphoma$2,683,519
P01 · FY2003 · CA
BMT Clinical Trial Network at Stanford$405,001
U01 · FY2003 · HL
Visualizing Tumors and Mechanisms of Therapy in Vivo$238,732
R01 · FY2003 · CA
Training Program in Hematopoietic Cell Transplantation$115,797
T32 · FY2003 · HL
Bone Marrow Grafting for Leukemia and Lymphoma$2,884,418
P01 · FY2002 · CA
BMT Clinical Trial Network at Stanford$150,001
U01 · FY2002 · HL
Training Program in Hematopoietic Cell Transplantation$111,935
T32 · FY2002 · HL
VISUALIZING TUMORS AND MECHANISMS OF THERAPY IN VIVO$60,203
R01 · FY2002 · CA
ALLOGRAFTING FOR LEUKEMIA$0
P01 · FY2002 · CA
CYTOKINE INDUCED KILLER CELLS AFTER AUTOLOGOUS/ALLOGENIC MARROW TRANSPLANTATION$0
P01 · FY2002 · CA
BONE MARROW GRAFTING FOR LEUKEMIA AND LYMPHOMA$2,582,252
P01 · FY2001 · CA
BMT Clinical Trial Netwrok at Stanford$405,001
U01 · FY2001 · HL
VISUALIZING TUMORS AND MECHANISMS OF THERAPY IN VIVO$180,607
R01 · FY2001 · CA
Training Program in Hematopoietic Cell Transplantation$98,556
T32 · FY2001 · HL
CYTOKINE INDUCED KILLER CELLS AFTER AUTOLOGOUS/ALLOGENIC MARROW TRANSPLANTATION$0
P01 · FY2001 · CA
CYTOKINE INDUCED KILLER CELLS AFTER AUTOLOGOUS/ALLOGENIC MARROW TRANSPLANTATION$221,448
P01 · FY2000 · CA
VISUALIZING TUMORS AND MECHANISMS OF THERAPY IN VIVO$175,968
R01 · FY2000 · CA
BONE MARROW GRAFTING FOR LEUKEMIA AND LYMPHOMA$158,762
P01 · FY2000 · CA
CYTOKINE INDUCED KILLER CELLS AFTER AUTOLOGOUS/ALLOGENIC MARROW TRANSPLANTATION$0
P01 · FY2000 · CA